Loading organizations...
Loading organizations...
Innovative screening platform for first-in-class cancer therapeutics.
Curve Therapeutics has raised $51.4M across 1 funding round.
Curve Therapeutics has raised $51.4M in total across 1 funding round.
Curve Therapeutics has raised $51.4M in total across 1 funding round.
Curve Therapeutics's investors include Advent Life Sciences, Ian Connatty, Columbus Venture Partners, Epidarex Capital.
Curve Therapeutics has raised $51.4M across 1 funding round. Most recently, it raised $51.4M Series A in February 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 27, 2024 | $51.4M Series A | Advent Life Sciences, Ian Connatty, Columbus Venture Partners, Epidarex Capital |